Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
A
s evidence-based interventions evolve, researchers examine their impact on co-morbid disorders. We examined prevalence of
co-morbid disorders in addition to cocaine dependence and their impact on abstinence outcomes. Data from a randomized
controlled trial comparing the effectiveness of abstinence contingent housing and work (CM) to the same CM components plus
manualized behavioral day treatment (CM+) were used. Disregarding original trial arm assignment, frequency of additional Axis
I Disorders was enumerated. New groups of No Additional Axis I Disorders and Additional Axis I were compared for abstinence
outcomes. The Beck Depression Inventory (BDI) was used as a proxy measure for the additional Axis I Disorder, Depression.
We examined impact of abstinence on depression symptoms as a function of four cohorts of consecutive weeks abstinent 0-6,
7-12, 13-18 and 19-24 weeks. In an auto-regressive cross-lagged Structural Equation Model (SEM) we examined the reciprocal
relationships between depression and abstinence. Most prevalent additional Axis I disorders were Depressive Disorders and
Anxiety Disorders. Co-morbid disorders did not affect abstinence. Cohorts with progressively more abstinence were linearly
related to lower depression. The SEM showed that longer abstinence predicted decreased depressive symptoms at two, six and
12 months. However, depressive symptoms did not predict changes in abstinence at any time point. Effects persisted over six
months of active treatment and 12 months of aftercare. With this effective substance abuse treatment, there was no difference in
abstinence associated with co-morbid disorders. Results suggest abstinence may play a more important role in reduced depression
than reduced depression plays in improved abstinence. If the unidirectional impact of targeted treatment on depression in recent
studies is replicated with other disorders, it may have important implications for standard treatment, and understanding the
nature of some depressive disorders as a general mood state often modifiable by changes in specific behavior domains
Biography
Jesse Milby is currently a Professor of Psychology at University of Alabama at Birmingham. He persued his B.A., English in 1962 from Eastern
Baptist College, St. Davids, PA, completed his Ph.D. in 1968 with the subjects of clinical Psychology from University of Alabama, Tuscaloosa, AL
and did Post-docs from three different institutes from University of London Institute of Psychiatry (Behavior Therapy), Temple University, Eastern
PA Psychiatric Institute (Behavior Therapy) & Johns Hopkins University (Clinical Psychopharm) during the period from 1977-2005. He also gain the
acknowledgement for many peer reviewed publications.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals